A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress

Journal of Experimental Medicine

Volumn 204, Issue 3, 2007, Pages 497-510

  Nombela Arrieta, César ^a   Mempel, Thorsten R ^b   Soriano, Silvia F ^a   Mazo, Irina ^b   Wymann, Matthias P ^c   Hirsch, Emilio ^d   Martínez A , Carlos ^e   Fukui, Yoshinori ^f   Von Andrian, Ulrich H ^b   Stein, Jens V ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF TURIN   (Italy)

^e CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^f KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CHEMOKINE RECEPTOR; F ACTIN; G PROTEIN COUPLED RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN DOCK2; PROTEIN KINASE B; RAC PROTEIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MOTILITY; CORRELATION COEFFICIENT; LYMPH NODE; LYMPHOCYTE; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL COMMUNICATION; CELL MOVEMENT; GTPASE-ACTIVATING PROTEINS; ISOENZYMES; LYMPH NODES; LYMPHOCYTES; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 33947411398     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20061780     Document Type: Article

References (62)

1. Cyster, J.G. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23:127-159.
2. von Andrian, U.H., and T.R. Mempel. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3:867-878.
3. Stein, J.V., and C. Nombela-Arrieta. 2005. Chemokine control of lymphocyte trafficking: a general overview. Immunology. 116:1-12.
4. Scimone, M.L., T.W. Felbinger, I.B. Mazo, J.V. Stein, U.H. Von Andrian, and W. Weninger. 2004. CXCL12 mediates CCR7-independent homing of central memory cells, but not naive T cells, in peripheral lymph nodes. J. Exp. Med. 199:1113-1120.
5. Ebisuno, Y., T. Tanaka, N. Kanemitsu, H. Kanda, K. Yamaguchi, T. Kaisho, S. Akira, and M. Miyasaka. 2003. Cutting edge: the B cell chemokine CXC chemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer's patches and affects B cell trafficking across high endothelial venules. J. Immunol. 171:1642-1646.
6. Ansel, K.M., V.N. Ngo, P.L. Hyman, S.A. Luther, R. Forster, J.D. Sedgwick, J.L. Browning, M. Lipp, and J.G. Cyster. 2000. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 406:309-314.
7. Förster, R., A.E. Mattis, E. Kremmer, E. Wolf, G. Brem, and M. Lipp. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 87:1037-1047.
8. Förster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Muller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 99:23-33.
9. Nakano, H., T. Tamura, T. Yoshimoto, H. Yagita, M. Miyasaka, E.C. Butcher, H. Nariuchi, T. Kakiuchi, and A. Matsuzawa. 1997. Genetic defect in T lymphocyte-specific homing into peripheral lymph nodes. Eur. J. Immunol. 27:215-221.
10. Bousso, P., and E.A. Robey. 2004. Dynamic behavior of T cells and thymocytes in lymphoid organs as revealed by two-photon microscopy. Immunity. 21:349-355.
11. Miller, M.J., S.H. Wei, I. Parker, and M.D. Cahalan. 2002. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science. 296:1869-1873.
12. Sumen, C., T.R. Mempel, I.B. Mazo, and U.H. von Andrian. 2004. Intravital microscopy: visualizing immunity in context. Immunity. 21:315-329.
13. Wei, S.H., I. Parker, M.J. Miller, and M.D. Cahalan. 2003. A stochastic view of lymphocyte motility and trafficking within the lymph node. Immunol. Rev. 195:136-159.
14. Dustin, M.L. 2004. Stop and go traffic to tune T cell responses. Immunity. 21:305-314.
15. Huang, A.Y., H. Qi, and R.N. Germain. 2004. Illuminating the landscape of in vivo immunity: insights from dynamic in situ imaging of secondary lymphoid tissues. Immunity. 21:331-339.
16. Bajénoff , M., J.G. Egen, L.Y. Koo, J.P. Laugier, F. Brau, N. Glaichenhaus, and R.N. Germain. 2006. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity. 25:989-1001.
17. Kaiser, A., E. Donnadieu, J.P. Abastado, A. Trautmann, and A. Nardin. 2005. CC chemokine ligand 19 secreted by mature dendritic cells increases naive T cell scanning behavior and their response to rare cognate antigen. J. Immunol. 175:2349-2356.
18. Stachowiak, A.N., Y. Wang, Y.C. Huang, and D.J. Irvine. 2006. Homeostatic lymphoid chemokines synergize with adhesion ligands to trigger T and B lymphocyte chemokinesis. J. Immunol. 177:2340-2348.
19. Han, S.B., C. Moratz, N.N. Huang, B. Kelsall, H. Cho, C.S. Shi, O. Schwartz, and J.H. Kehrl. 2005. Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity. 22:343-354.
20. Rosen, H., G. Sanna, and C. Alfonso. 2003. Egress: a receptor-regulated step in lymphocyte trafficking. Immunol. Rev. 195:160-177.
21. Mandala, S., R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G.J. Shei, D. Card, C. Keohane, et al. 2002. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 296:346-349.
22. Brinkmann, V., M.D. Davis, C.E. Heise, R. Albert, S. Cottens, R. Hof, C. Bruns, E. Prieschl, T. Baumruker, P. Hiestand, et al. 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277:21453-21457.
23. Gräler, M.H., and E.J. Goetzl. 2004. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 18:551-553.
24. Matloubian, M., C.G. Lo, G. Cinamon, M.J. Lesneski, Y. Xu, V. Brinkmann, M.L. Allende, R.L. Proia, and J.G. Cyster. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 427:355-360.
25. Halin, C., M.L. Scimone, R. Bonasio, J.M. Gauguet, T.R. Mempel, E. Quackenbush, R.L. Proia, S. Mandala, and U.H. von Andrian. 2005. The S1P-analog FTY720 differentially modulates T cell homing via HEV: T cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer's patches. Blood. 106:1314-1322.
26. Brugnera, E., L. Haney, C. Grimsley, M. Lu, S.F. Walk, A.C. Tosello-Trampont, I.G. Macara, H. Madhani, G.R. Fink, and K.S. Ravichandran. 2002. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat. Cell Biol. 4:574-582.
27. Cote, J.F., and K. Vuori. 2002. Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity. J. Cell Sci. 115:4901-4913.
28. Reif, K., and J. Cyster. 2002. The CDM protein DOCK2 in lymphocyte migration. Trends Cell Biol. 12:368-373.
29. Etienne-Manneville, S., and A. Hall. 2002. Rho GTPases in cell biology. Nature. 420:629-635.
30. Fukui, Y., O. Hashimoto, T. Sanui, T. Oono, H. Koga, M. Abe, A. Inayoshi, M. Noda, M. Oike, T. Shirai, and T. Sasazuki. 2001. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature. 412:826-831.
31. Nombela-Arrieta, C., R.A. Lacalle, M.C. Montoya, Y. Kunisaki, D. Megias, M. Marques, A.C. Carrera, S. Manes, Y. Fukui, A.C. Martinez, and J.V. Stein. 2004. Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. Immunity. 21:429-441.
32. Reif, K., K. Okkenhaug, T. Sasaki, J.M. Penninger, B. Vanhaesebroeck, and J.G. Cyster. 2004. Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J. Immunol. 173:2236-2240.
33. Mempel, T.R., S.E. Henrickson, and U.H. Von Andrian. 2004. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature. 427:154-159.
34. Spiegel, S., and S. Milstien. 2002. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 277:25851-25854.
35. Spiegel, S., and S. Milstien. 2003. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4:397-407.
36. Durand, C.A., J. Westendorf, K.W. Tse, and M.R. Gold. 2006. The Rap GTPases mediate CXCL13- and sphingosine1-phosphate-induced chemotaxis, adhesion, and Pyk2 tyrosine phosphorylation in B lymphocytes. Eur. J. Immunol. 36:2235-2249.
37. Lo, C.G., Y. Xu, R.L. Proia, and J.G. Cyster. 2005. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J. Exp. Med. 201:291-301.
38. Graeler, M., and E.J. Goetzl. 2002. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J. 16:1874-1878.
39. Shulman, Z., R. Pasvolsky, E. Woolf, V. Grabovsky, S.W. Feigelson, N. Erez, Y. Fukui, and R. Alon. 2006. DOCK2 regulates chemokine-triggered lateral lymphocyte motility but not transendothelial migration. Blood. 108:2150-2158.
40. Wei, S.H., H. Rosen, M.P. Matheu, M.G. Sanna, S.K. Wang, E. Jo, C.H. Wong, I. Parker, and M.D. Cahalan. 2005. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat. Immunol. 6:1228-1235.
41. Ward, S.G. 2004. Do phosphoinositide 3-kinases direct lymphocyte navigation? Trends Immunol. 25:67-74.
42. Mañes, S., R. Ana Lacalle, C. Gomez-Mouton, and A.C. Martínez. 2003. From rafts to crafts: membrane asymmetry in moving cells. Trends Immunol. 24:320-326.
43. Hannigan, M., L. Zhan, Z. Li, Y. Ai, D. Wu, and C.K. Huang. 2002. Neutrophils lacking phosphoinositide 3-kinase gamma show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc. Natl. Acad. Sci. USA. 99:3603-3608.
44. Li, Z., M. Hannigan, Z. Mo, B. Liu, W. Lu, Y. Wu, A.V. Smrcka, G. Wu, L. Li, M. Liu, et al. 2003. Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of Cdc42. Cell. 114:215-227.
45. Luther, S.A., H.L. Tang, P.L. Hyman, A.G. Farr, and J.G. Cyster. 2000. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl. Acad. Sci. USA. 97:12694-12699.
46. Okada, T., M.J. Miller, I. Parker, M.F. Krummel, M. Neighbors, S.B. Hartley, A. O'Garra, M.D. Cahalan, and J.G. Cyster. 2005. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol. 3:e150.
47. Castellino, F., A.Y. Huang, G. Altan-Bonnet, S. Stoll, C. Scheinecker, and R.N. Germain. 2006. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature. 440:890-895.
48. Bardi, G., M. Lipp, M. Baggiolini, and P. Loetscher. 2001. The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC. Eur. J. Immunol. 31:3291-3297.
49. Kabashima, K., T. Murata, H. Tanaka, T. Matsuoka, D. Sakata, N. Yoshida, K. Katagiri, T. Kinashi, T. Tanaka, M. Miyasaka, et al. 2003. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4:694-701.
50. Sanui, T., A. Inayoshi, M. Noda, E. Iwata, M. Oike, T. Sasazuki, and Y. Fukui. 2003. DOCK2 is essential for antigen-induced translocation of TCR and lipid rafts, but not PKC-theta and LFA-1, in T cells. Immunity. 19:119-129.
51. Kharel, Y., S. Lee, A.H. Snyder, L. Sheasley-O'neill, M.A. Morris, Y. Setiady, R. Zhu, M.A. Zigler, T.L. Burcin, K. Ley, et al. 2005. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J. Biol. Chem. 280:36865-36872.
52. Zemann, B., B. Kinzel, M. Muller, R. Reuschel, D. Mechtcheriakova, N. Urtz, F. Bornancin, T. Baumruker, and A. Billich. 2006. Sphingosine kinase type 2 is essential for lymphopenia induced by the immuno-modulatory drug FTY720. Blood. 107:1454-1458.
53. Singer, I.I., M. Tian, L.A. Wickham, J. Lin, S.S. Matheravidathu, M.J. Forrest, S. Mandala, and E.J. Quackenbush. 2005. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes. J. Immunol. 175:7151-7161.
54. Sanna, M.G., S.K. Wang, P.J. Gonzalez-Cabrera, A. Don, D. Marsolais, M.P. Matheu, S.H. Wei, I. Parker, E. Jo, W.C. Cheng, et al. 2006. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P(1) antagonist in vivo. Nat. Chem. Biol. 2:434-441.
55. 1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem. Biol. 12:703-715.
56. 1, on T-cells controls thymic emigration. J. Biol. Chem. 279:15396-15401.
57. 1 and lymphocyte egress from lymphoid organs. Nature. 440:540-544.
58. Schwab, S.R., J.P. Pereira, M. Matloubian, Y. Xu, Y. Huang, and J.G. Cyster. 2005. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science. 309:1735-1739.
59. Bandhuvula, P., Y.Y. Tam, B. Oskouian, and J.D. Saba. 2005. The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. J. Biol. Chem. 280:33697-33700.
60. Stein, J.V., A. Rot, Y. Luo, M. Narasimhaswamy, H. Nakano, M.D. Gunn, A. Matsuzawa, E.J. Quackenbush, M.E. Dorf, and U.H. von Andrian. 2000. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191:61-76.
61. Graeler, M., G. Shankar, and E.J. Goetzl. 2002. Cutting edge: suppression of T cell chemotaxis by sphingosine 1-phosphate. J. Immunol. 169:4084-4087.
62. Jiang, H., F. Pan, L.M. Erickson, M.S. Jang, T. Sanui, Y. Kunisaki, T. Sasazuki, M. Kobayashi, and Y. Fukui. 2005. Deletion of DOCK2, a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection. J. Exp. Med. 202:1121-1130.